Improved patient satisfaction and pain evolution with almotriptan in migraine: a primary care study

References

• Goadsby PJ, Lipton RB, Ferrari MD. Migraine- current understanding and treatment. N Engl J Med 2002;346:257-70
   PubMed Web of Science ®Google Scholar
• Menken M, Munsat TL, Toole JF. The global burden of disease study- implications for neurology. Arch Neurol 2000;57:418-20
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Preventive migraine treatment. Neurol Clin 2009;27:429-43
   PubMed Web of Science ®Google Scholar
• Fumal A, Schoenen J. Current migraine management- patient acceptability and future approaches. Neuropsychiatr Dis Treat 2008;4:1043-57
   PubMedGoogle Scholar
• Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol 2006;13:560-72
   PubMed Web of Science ®Google Scholar
• Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia 2007;27:394-402
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Sprenger T. Migraine pathogenesis and state of pharmacological treatment options. BMC Med 2009;7:71
   PubMedGoogle Scholar
• Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5–HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002;22:633-58
   PubMed Web of Science ®Google Scholar
• Welch KMA, Mathew NT, Stone P, et al. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000;20:687-94
   PubMed Web of Science ®Google Scholar
• Humphrey PPA, Feniuk W, Perren MJ, et al. Serotonin and migraine. Ann NY Acad Sci 1990;600:587-98
   PubMed Web of Science ®Google Scholar
• Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med 1993;44:145-54
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. The pathophysiology of headache. In: Silberstein SD, Lipton RB, Soloman S, eds. Wolff’s Headache and Other Head Pain, 7th edn. Oxford: Oxford University Press, 2001:57-72
   Google Scholar
• Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia 2008;28:383-91
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Saxana PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 2000;123:9-18
   PubMed Web of Science ®Google Scholar
• Bou J, Gras J, Cortijo J, Morcillo EJ, et al. Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries. Cephalalgia 2001;21:804-12
   PubMed Web of Science ®Google Scholar
• Pascual J, Falk RM, Piessens F, et al. Consistent efficacy and tolerability of almotriptan in the acuste treatment of multiple migraine attacks: results of a large randomized, double-blind placebo-controlled study. Cephalalgia 2000;20:588-96
   PubMed Web of Science ®Google Scholar
• Deleu D, Hanssens Y. Current and emerging second-generation triptans in acute migraine therapy: a comparative review. J Clin Pharmacol 2000;40:687-700
   PubMed Web of Science ®Google Scholar
• Créac'h C, Radat F, Mick G, et al. One or several types of triptan overuse headaches? Headache 2009;49:519-28
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. The ‘Act when mild’ (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia 2008;28:36-41
   PubMed Web of Science ®Google Scholar
• Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol 1991;31:295-9
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Block G, Dahlöf C, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20:765-86
   PubMed Web of Science ®Google Scholar
• Cady RK, Lipton RB, Hall C, et al. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 2000;40:792-7
   PubMed Web of Science ®Google Scholar
• Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000;22:1035-48
   PubMed Web of Science ®Google Scholar
• Linde M, Mellberg A, Dahlöf C. The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan. Cephalalgia 2006;26:712-21
   PubMed Web of Science ®Google Scholar
• Mathew NT, Finlayson G, Smith TR, et al. Early intervention with almotriptan: results of the AEGIS trial (AXERT® Early Migraine Intervention Study). Headache 2007;47:189-98
   PubMed Web of Science ®Google Scholar
• Lucas C, Géraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache 2006;46:715-25
   PubMed Web of Science ®Google Scholar
• Shapero G, Dowson A, Lacoste JP, et al. Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet. In J Clin Pract 2006;60:1530-5
   PubMed Web of Science ®Google Scholar
• Lanteri-Minet M, Diaz-Insa S, Leone M, et al. Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study. Int J Clin Pract 2010;64:936-43
   PubMed Web of Science ®Google Scholar
• [IHS 2004] Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004;24:1-160
   Google Scholar
• Géraud G, Lanteri-Minet M, Lucas C. on behalf of the French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 2004;26:1305-18
   PubMed Web of Science ®Google Scholar
• Pointer JS. A novel visual analogue scale (VAS) device: an instrument based on the VAS designed to quantify the subjective visual experience. Ophthal Physiol Opt 2004;24:181-5
   PubMed Web of Science ®Google Scholar
• Colman SS, Brod MI, Krishnamurthy A, et al. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan. Clin Ther 2001;23:127-45
   PubMed Web of Science ®Google Scholar
• Láinez MJA, Galván J, Heras J, et al. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. Eur J Neurol 2007;14:269-75
   PubMed Web of Science ®Google Scholar
• Massiou H, Pradalier A, Donnet A, et al. Evaluation of efficacy, tolerability and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. Eur Neurol 2006;55:198-203
   PubMed Web of Science ®Google Scholar
• Diener HC, Dodick DW, Goadsby PJ, et al. Identification of negative predictors of pain0free response to triptans. Analysis of the eletriptan database. Cephalalgia 2007;28:35-40
   PubMed Web of Science ®Google Scholar
• Mondell BE. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine. Clin Ther 2003;25:331-41
   PubMed Web of Science ®Google Scholar
• Pascual J, Diener HC. Use of almotriptan in triptan-experiences and triptan-naїve patients. Curr Med Res Opin 2007;23:2433-40
   PubMed Web of Science ®Google Scholar
• Christoph-Diener H, Ferrari M, Mansbach H. Predicting the response to sumatriptan: the sumatriptan naratritan aggregate patient database. Neurology 2004;63:520-4
   PubMed Web of Science ®Google Scholar
• Gracia-Naya M, Alarcia-Alejos R, Modrego-Pardo PJ. The importance of chronic migraine in a general neurology service. Rev Neurol 2008;46:577-81
   PubMed Web of Science ®Google Scholar
• Vincent MB, de Carvalho JJ. Primary headache care delivery by nonspecialists in Brazil. Brazilian Headache Care Cooperative Group. Cephalalgia 1999;19:520-4
   PubMedGoogle Scholar
• Allais G, Acuto G, Cabarrocas X, et al. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006;27:S193-7
   PubMed Web of Science ®Google Scholar
• Allais G, Bussone G, De Lorenzo C, et al. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol Sci 2005;26:S125-9
   Google Scholar
• Martin VT. Menstrual migraine: a review of prophylactic therapies. Curr Pain Headache Rep 2004;8:229-37
   PubMedGoogle Scholar
• Ng-Mak DS, Cady R, Chen YT, et al. Can migraineurs accurately identify their headaches as ‘migraine’ at attack onset? Headache 2007;47:645-53
   PubMed Web of Science ®Google Scholar